MSL

Medical Advisor neuroscience / vascular surgery / rare diseases
Implementation the medical strategy through formation of long­term partnership scientific relations with healthcare professionals to support products and image of the Company.
Support for the company's global clinical trials and external research initiatives.
Supporting marketing in terms of expertise issues.
Developing key opinion leaders and leading specialists.
Arrangement of scientific and medical preparation and support of authorization.
Planning early access programs.
Providing medical trainings for sales team.
Participation in cross-functional projects.
Achievements:
I took part in conduction and completion the international Medical Affairs Company Study dedicated to Actovegin in case of PAD as a science lead. The main data were reflected in a article which was successfully submitted and published in the International Angiology journal https://pubmed.ncbi.nlm.nih.gov/36264097/. Based on these data, Actovegin was included in the appropriate clinical guide. The instruction for medical using was updated.
Support for the implementation of several Investigator Initiated Studies in neurology and vascular surgery. These led to increasing an evident base of company’s brands.
Development and implementation of the concept of the using of Actovegin in post-COVID cognitive disorders that was reflected in the inclusion of Actovegin in appropriate clinical guideline.
Ceraхon, one of the brands in the area of responsibility, showed steady growth, despite the abundance of generics. Ceraxone was included in federal guidelines for the management of stroke patients.
Interaction with KOLs was improved dramatically. KOLs have begun implement justification of choosing company’s brands in their lectures making competitor analysis. New forms of lectures were implemented in way of discussion of two or more speakers.
Making prelaunch activities for rare epilepsy brand. The most relevant KOL were defined. Russia was included in international Medical Affairs Company study. Four sites were defined. Four eligible patients were detected. It opened the way for prompt registration.
Creation and implementation of an electronic system for training employees on medical issues. That led to improving the medical knowledge of field force.

Implementation the marketing strategy in Volga area.
Interaction with marketing in frames of cycle book preparation.
Analysis of sales, MS, SoV, DI, MR et cet.
Allocation of budgets on regions of Volga area.
Developing of regional KOLs.
Developing of field force in terms of medical knowledge.
Achievements:
The brands of the area of responsibility on Volga area had the highest Ceraxon MS in 2013FY. As a result I was recognized as the best Product Specialist of Russia.
Successful launch and support of two brands in multiple sclerosis.

Liability for sales in areas of responsibility.
Development of long-term interaction with HCPs.
Achievements:
I was recognized as the best MR in 2010FY.

Over 40 articles were published in interregional collections of scientific works and national journals.
Regularly participate in national scientific conferences and made reports.
Involving in organization of the Kirov region’s All-Russian Scientific Society of Anatomists, Histologists and Embryologists as a scientific secretary